Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

Bacterial Signaling

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

From Theory to Empathy: Integrating Human-Centered Design and Lived Experiences in e-Health Engineering Education.

Studies in health technology and informatics·2026

Same author

Barriers and facilitators to the implementation and use of computerized clinical decision support systems for predicting and managing in-patient clinical deterioration: a systematic review of qualitative research.

International journal of medical informatics·2026

Same author

Ru-Catalyzed Asymmetric Transfer Hydrogenation of α-iminophosphonates: A Novel Synthetic Approach for Valuable Chiral α-Aminophosphonates.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025

Same author

Integrate Usability Evaluation into Clinical Investigation: Why, When and How?

Studies in health technology and informatics·2025

Same author

Advance care planning procedure in older patients at a high risk of death after discharge from the acute geriatric unit: A study protocol.

Archives of gerontology and geriatrics·2025

Same author

Augmented Reality Eyewear for Assisting in the Preparation and Control of Cancer Therapies: Assessing the Learning Curve and Level of Adoption.

Studies in health technology and informatics·2024

Search research articles

Related Experiment Video

Updated: May 14, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Software as a medical device: regulatory critical issues.

Sylvia Pelayo¹, Sabrina Bras Da Costa, Nicolas Leroy

¹Université Lille Nord de France, Lille, France. sylvia.pelayo@univ-lille2.fr

Studies in Health Technology and Informatics

|February 8, 2013

Summary

The EU

Area of Science:

Medical Device Regulation
Health Informatics
Software Engineering

Background:

The European Union adopted the revised Medical Device Directive in 2010.
Software used for specific medical purposes is now classified as a medical device.
This classification necessitates a re-evaluation of medical software lifecycle management.

Purpose of the Study:

To identify and discuss key issues arising from the new classification of medical software.
To explore the implications for the design, development, evaluation, and post-market surveillance of medical software.
To propose a new perspective on managing medical software as a medical device.

Main Methods:

Literature review of the revised Medical Device Directive.
Analysis of regulatory changes impacting medical software.

Related Experiment Videos

Last Updated: May 14, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Identification of challenges and considerations for medical device manufacturers and regulators.

Discussion of potential solutions and future directions.

Main Results:

The revised directive significantly impacts the regulatory landscape for medical software.
New considerations are required for the entire lifecycle of software classified as a medical device.
Specific challenges exist in areas like validation, risk management, and post-market surveillance for medical software.

Conclusions:

A comprehensive approach is needed for the design, development, and surveillance of medical software.
Regulatory frameworks must adapt to the evolving nature of medical technology.
Further research and guidance are necessary to address the complexities of medical software regulation.